Interpretation of our results might rely on differential requirements of activated STATs (STAT3/5) during CML clone development and maintenance, including the observation of RNLS rise upon TKI introduction. The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.